Interim results from a study in China suggest ivonescimab may reduce the risk of death versus Keytruda, but the difference ...

Spruce Biosciences is cutting over half of its employees as it looks to secure accelerated approval of a Sanfilippo syndrome ...

Tonix has no tonic for cocaine intoxication, with the biopharma terminating a midstage trial for the condition amid poor ...

ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced ...

Industry Veteran Brings 30 Years of Experience in Finance, Strategy and Operations WALTHAM, Mass., April 28, 2025 (GLOBE ...

CCRCs are helping Healthpeak Properties offset “weakness” in the laboratory segment of its portfolio, President and CEO Scott ...

Helix BioPharma, a clinical-stage biopharmaceutical company, commits to innovating with purpose in this challenging landscape ...

Sutro Biopharma, Inc.’s STRO share price has dipped by 15.38%, which has investors questioning if this is right time to buy.

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to ...

Grove Biopharma has raised a $30 million series A round to develop Bionic Biologics, also known as protein-like polymers (PLP ...

Perhaps no industry is as reliant on grant-funded university research as is bioscience, the companies that develop ...

Grove Biopharma's move from an incubator to a stand-alone headquarters illustrates Trammell Crow's strategy for the lab ...